CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.
Lymphocytes bearing the CD8 marker were shown to suppress replication of human immunodeficiency virus (HIV) in peripheral blood mononuclear cells. The effect was dose-dependent and most apparent with autologous lymphocytes; it did not appear to be mediated by a cytotoxic response. This suppression of HIV replication could be demonstrated by the addition of CD8+ cells at the initiation of virus production as well as after several weeks of virus replication by cultured cells. The observations suggest a potential approach to therapy in which autologous CD8 lymphocytes could be administered to individuals to inhibit HIV replication and perhaps progression of disease.
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology* / Q000628:therapy; D000954:Antigens, Surface; D002478:Cells, Cultured; D006678:HIV / Q000276:immunology / Q000502:physiology*; D006801:Humans; D008297:Male; D012194:RNA-Directed DNA Polymerase / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology*; D014779:Virus Replication
D000954:Antigens, Surface; D012194:RNA-Directed DNA Polymerase